Article
Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosis.
Pharmacological reports : PR - 1 Jan 2012
Barańska Małgorzata, Dziankowska-Bartkowiak Bożena, Waszczykowska Elżbieta, Rychlik-Sych Mariola, Skrętkowicz Jadwiga
Abstract excerpt
BACKGROUND: Systemic sclerosis (SSc) belongs to the group of systemic diseases of the connective tissue, which are characterized by a chronic autoimmune inflammatory process. The studies on etiopathogenesis of autoimmune diseases focus on the impact the genetically conditioned impairment of xenobiotic metabolism may exert. The genetically polymorphic CYP2D6 is one of the most important phase I drug metabolizing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
